Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2056 AL 2070

Imaging Markers in Genetic Forms of Parkinson's Disease

Droby A, Thaler A, Mirelman A.

Brain Sci. 2023 Aug 16;13(8):1212. doi: 10.3390/brainsci13081212.

REM Behavior Disorder: Implications for PD Therapeutics

Feuerstein JS, Amara A.

Curr Neurol Neurosci Rep. 2023 Nov;23(11):727-734. doi: 10.1007/s11910-023-01310-1. Epub 2023 Oct 13.

Restoring autophagic function: a case for type 2 diabetes mellitus drug repurposing in Parkinson's disease

Greco M, Munir A, Musarò D, Coppola C, Maffia M.

Front Neurosci. 2023 Nov 3;17:1244022. doi: 10.3389/fnins.2023.1244022. eCollection 2023.

Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson's Disease

Gonzalez-Alcocer A, Duarte-Jurado AP, Soto-Dominguez A, Loera-Arias MJ, Villarreal-Silva EE, Saucedo-Cardenas O, de Oca-Luna RM, Garcia-Garcia A, Rodriguez-Rocha H.

Int J Mol Sci. 2023 Jan 9;24(2):1256. doi: 10.3390/ijms24021256.

Targeting epigenetic modifications in Parkinson's disease therapy

Zhang D, Zhang J, Wang Y, Wang G, Tang P, Liu Y, Zhang Y, Ouyang L.

Med Res Rev. 2023 Sep;43(5):1748-1777. doi: 10.1002/med.21962. Epub 2023 Apr 29.

Closed-Loop Adaptive Deep Brain Stimulation in Parkinson's Disease: Procedures to Achieve It and Future Perspectives

Wang S, Zhu G, Shi L, Zhang C, Wu B, Yang A, Meng F, Jiang Y, Zhang J.

J Parkinsons Dis. 2023;13(4):453-471. doi: 10.3233/JPD-225053.

Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson's disease

He T, Lin X, Su A, Zhang Y, Xing Z, Mi L, Wei T, Li Z, Wu W.

Front Pharmacol. 2023 May 10;14:1117337. doi: 10.3389/fphar.2023.1117337. eCollection 2023.

Orexin pathway in Parkinson's disease: a review

Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Zaafar D, Batiha GE.

Mol Biol Rep. 2023 Jul;50(7):6107-6120. doi: 10.1007/s11033-023-08459-5. Epub 2023 May 8.

Uncovering Novel Therapeutic Targets for Parkinson's Disease

Soni R, Delvadia P, Joharapurkar A, Shah J.

ACS Chem Neurosci. 2023 Jun 7;14(11):1935-1949. doi: 10.1021/acschemneuro.3c00084. Epub 2023 May 25.

Bioinorganic Chemistry of Micronutrients Related to Alzheimer's and Parkinson's Diseases

Kola A, Nencioni F, Valensin D.

Molecules. 2023 Jul 17;28(14):5467. doi: 10.3390/molecules28145467.

Retinal Changes in Parkinson's Disease: A Non-invasive Biomarker for Early Diagnosis

Subramaniam MD, Aishwarya Janaki P, Abishek Kumar B, Gopalarethinam J, Nair AP, Mahalaxmi I, Vellingiri B.

Cell Mol Neurobiol. 2023 Nov;43(8):3983-3996. doi: 10.1007/s10571-023-01419-4. Epub 2023 Oct 13.

The therapeutic effects of yoga in people with Parkinson's disease: a mini-review

Zhang T, Liu W, Bai Q, Gao S.

Ann Med. 2023;55(2):2294935. doi: 10.1080/07853890.2023.2294935. Epub 2023 Dec 18.

Parkinson's disease therapy: what lies ahead?

Wolff A, Schumacher NU, Pürner D, Machetanz G, Demleitner AF, Feneberg E, Hagemeier M, Lingor P.

J Neural Transm (Vienna). 2023 Jun;130(6):793-820. doi: 10.1007/s00702-023-02641-6. Epub 2023 May 5.

Potential for Therapeutic-Loaded Exosomes to Ameliorate the Pathogenic Effects of α-Synuclein in Parkinson's Disease

Rademacher DJ.

Biomedicines. 2023 Apr 17;11(4):1187. doi: 10.3390/biomedicines11041187.

Astrocytes in Parkinson's Disease: From Role to Possible Intervention

Wang T, Sun Y, Dettmer U.

Cells. 2023 Sep 22;12(19):2336. doi: 10.3390/cells12192336.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias